Cipher Pharmaceuticals Inc T.CPH

Alternate Symbol(s): CPHRF

Healthcare

Cipher Pharmaceuticals Inc. is a Canada-based specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products either directly in Canada or indirectly through partners in Canada, the United States and South America. Its Dermatology products include Actikerall, Epuris, Ozanex and Vaniqa. Its Hospital Acute Care products include Aggrastat and Brinavess. Its Out-Licensed products include Absorica, ConZip and Lipofen. The Company is also focused on building a portfolio of prescription medicines that serve unmet medical needs. The Company's product pipeline development programs including MOB-015, DTR-001, and CF-101. The Company's subsidiaries include Cipher US Holdings Inc., Cipher US Holdco LLC, and Cipher Pharmaceuticals US LLC.

TSX:CPH - Post by User

Cipher Pharmaceuticals Inc

Bullboard Posts

Comment by mystiqeon Jul 30, 2013 4:38pm

119 Views

Post# 21639890

RE:RE:Note to mystique

Thank you for your interest in Cipher Pharmaceuticals.

The Press Release with the Q2 results will be issued tomorrow morning prior to Markets opening and we will also be hosting a conference call for Q2 2013 financial results at 8:30 am. Details are below on how to join the call.

Q2 2013 CONFERENCE CALL

WHEN: Wednesday, July 31, 2013 at 8:30AM ET

Bullboard Posts

Two diversified junior mining stocks to hitch your portfolio to